Strides Pharma Science Limited (BOM:532531)
India · Delayed Price · Currency is INR 992.05
+35.05 (3.66%)
At close: Aug 20, 2026
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 88.26 billion as of August 20, 2026. Its market cap has increased by 10.13% in one year.
Market Cap
88.26B
Enterprise Value
104.21B
Revenue
50.04B
Ranking
n/a
PE Ratio
14.39
Stock Price
992.05
ChartMarket Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 88.26B, an increase of 1,077.69%. That is a compound annual growth rate of 9.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 91.53B | 10.29% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 191.25B |
| Jubilant Pharmova | 137.05B |
| CORONA Remedies | 129.62B |
| Viyash Scientific | 111.15B |
| Procter & Gamble Health | 95.94B |
| Sanofi India | 74.58B |
| Bliss GVS Pharma | 57.95B |
| FDC Limited | 57.17B |